Kansas City Life (KCL) Signature Term Express-Simple Issue term-SI term

Carrier: Kansas City Life Insurance Company

Product: Signature Term Express (STE) and Signature Term Express ROP (STE ROP)

Product Types: 10-, 15-, 20-, 30-Year Level Term (STE); 20-, 25-, 30-Year ROP (STE ROP)

Issue Ages: STE: 10-Year (18–70), 15-Year (18–65), 20-Year (18–60), 30-Year (18–50); STE ROP: 20-Year (20–55), 25-Year (20–50), 30-Year (20–50)

Face Amounts: Minimum $50,000; Maximum $300,000 (Ages 18–65), $150,000 (Ages 66–70)

Target Market: Mortgage protection, short-term income replacement, return-of-premium term

Product Overview

Signature Term Express is a simplified issue term life insurance product with rapid underwriting and competitive pricing. It is designed for clients seeking efficient mortgage protection and short-term income replacement. Available in 10-, 15-, 20-, and 30-year level term durations, the product also offers Return of Premium (ROP) options in 20-, 25-, and 30-year terms. STE policies provide automatic living benefit riders and several optional riders to enhance flexibility.

Issue Ages and Face Amounts

For STE (non-ROP):

• 10-Year Term: Ages 18–70

• 15-Year Term: Ages 18–65

• 20-Year Term: Ages 18–60

• 30-Year Term: Ages 18–50

For STE ROP:

• 20-Year ROP: Ages 20–55

• 25-Year ROP: Ages 20–50

• 30-Year ROP: Ages 20–50

Minimum Face Amount: $50,000
Maximum Face Amount:

• Ages 18–65: $300,000

• Ages 66–70: $150,000

Available Plan Types

• Signature Term Express (10, 15, 20, 30 year level term)

• Signature Term Express ROP (20, 25, 30 year return-of-premium)

Underwriting Overview

STE is issued on a simplified issue basis. There are no medical exams required, but underwriting utilizes the following tools:

• MIB, MVR, and Risk Score: Used across all applications.

• APS: May be ordered for face amounts $250,001–$300,000 or for older ages.

• Build Chart: Evaluated in underwriting.

• Mandatory MVR:

  • Ages 18–45 (STE)

  • Ages 20–45 (STE ROP)

Diabetes Guidelines:

• Declined if diagnosed before age 50

• Declined for insulin use at any age

• Declined if diabetic with complications

Mortgage Requirement: Applicant must have purchased or refinanced a home in the past 2 years. Application must include mortgage loan amount and financial institution name.

Visa Requirements:

• Acceptable Visas: Permanent Residency, H1B, L1

• Must reside in U.S. for a minimum of 1 year

• Must provide I-94, I-797A, or residency documentation

Prescription Medication Exclusions

Applicants currently taking any of the following medications are not eligible and will be automatically declined. The complete exclusion list includes:

Abacavir, Abilify, Adcirca, Aggrenox, Alkeran, Amiodarone, Ampyra, Antabuse, Anoro Ellipta, Aricept, Arimidex, Atripla, Avonex, Azilect, Baraclude, Betaseron, Breo Ellipta, Buprenorphine (Subutex), Calcium Acetate, Campath, Campral, Caprelsa, Carbidopa/Levodopa, Casodex, Cayston, Cellcept, Chlorpromazine Hcl, Clozapine, Cognex, Combivir, Comtan, Copaxone, Crixivan, Cyclosporine, Cytoxan, Daklinza, Daliresp, Descovy, Digitek, Digoxin, Dobutamine Hcl, Donepezil, Droxia, Eldepryl, Eligard, Eliquis, Eminase, Enbrel, Entresto, Erythropoietin, Epivir Hbv, Ergoloid Mesylates, Exelon, Fanapt, Femara, Flecainide, Fluorouracil, Galantamine Hydrobromide, Gammagard, Gamunex, Gengraf, Genvoya, Geodon, Haldol, Haloperidol, Harvoni, Hepsera, Humira, Hydrea, Hydroxyurea, Infergen, Inspra, Insulin, Invega, Invirase, Isentress, Kaletra, Kalydeco, Keytruda, Lamictal, Lanoxin, Latuda, Leucovorin Calcium, Lexiva, Limbitrol, Lithium, Megestrol Acetate (Megace), Mercaptopurine, Methadone, Methotrexate, Mitomycin, Morphine Sulfate, Mycophenolate Mofetil, Myfortic, Nabi-Hb, Naloxone Hcl, Naltrexone Hcl, Namenda, Neupogen, Nitroglycerin, Odefsey, Olysio, Opdivo, Panretin, Pegasys, Peg-Intron, Perphenazine, Pradaxa, Prograf, Quinidine, Ranexa, Razadyne, Rebif, Retrovir, Revia, Revlimid, Rexulti, Rhythmol, Ribavirin, Rilutek, Risperdal, Rituxan, Sandimmune, Saphris, Seroquel, Serzone, Sinemet, Sotalol, Sovaldi, Spiriva, Stalevo, Stribild, Suboxone, Sustiva, Symbyax, Tamoxifen, Targretin, Temodar, Teslac, Tikosyn, Tolcapone, Truvada, Tudorza, Tysabri, Viracept, Viramune, Viread, Vraylor, Xarelto, Xeljanz, Yervoy, Zenapax, Zemplar, Zerit, Ziagen, Zidovudine, Zoladex, Zyprexa

Individual Consideration Medications: The following drugs may be accepted with explanation provided on the application: Carvedilol, Clopidogrel, Coreg, Coumadin, Enoxaparin Sodium, Lovenox, Prednisone, Plavix, Warfarin

Riders and Living Benefits

Included at No Cost:

• Accelerated Death Benefit (ADB) – Chronic, Critical, and Terminal Illness

• Waiver of Premium for Residential Damage

• Waiver of Premium for Unemployment

Optional Riders:

• ADB – Accidental Death Benefit (Issue Ages 18–60 STE; 20–55 ROP)

• CTI – Children’s Term Insurance (14 days–17 years)

• IAO – Income Assured Option (Installment Death Benefit Option)

• WP – Waiver of Premium (Issue Ages 18–55 STE; 20–55 ROP)

Conversion Options

• Available after Year 2 through earlier of Policy Year 12 or Age 65

• 10-Year Term: convertible only through Year 10 or Age 65 (whichever is sooner)

• Converts to eligible Kansas City Life permanent plans

• No evidence of insurability required

• Conversion not allowed if premiums are currently waived under WP rider

Additional Provisions

• Reinstatement: Allowed within 3 years with proof of insurability and back premiums + 6% interest

• Prepaid Premium Discount: Available on annual premiums only (not allowed with ROP plans)

• STE ROP Features:

  • Tax-free return of base premiums (excludes riders) if policy is outlived

  • Extended term or paid-up insurance available at lapse (nonforfeiture options)

  • Automatic premium loan option available upon request

  • Loans available with 8% annual interest, repayable by cash value

This guide is intended for internal agent use only and is based on Kansas City Life's most recent specifications and agent material.